倒钩主动固定对胸主动脉腔内修复术结局影响的回顾性分析
ZTEG组1年迁移率2%、最大随访20%,匹配比较显示ZTEG组1年迁移率显著更低(4% vs 35%;p=0.04),最大随访迁移距离更短(中位4mm vs 10mm;p=0.016),而rTAAD、Ia型内漏和近端再干预无差异。
要点
- 倒钩固定ZTEG在主动脉综合征患者中1年迁移率2%,最大随访20%。
- 匹配比较显示ZTEG较非主动固定ZDEG显著降低1年迁移率(4% vs 35%)。
- 两组rTAAD、Ia型内漏和近端再干预率无显著差异。
核心结论
- 在主动脉综合征患者中,使用倒钩介导固定的ZTEG与无主动固定的ZDEG相比,迁移和迁移距离减少,且rTAAD、Ia型内漏或近端再干预无差异。
研究设计与样本
- 单中心回顾性分析,遵循STROBE指南,纳入2011年1月至2024年6月接受ZTEG治疗的主动脉综合征患者,排除近端锚定区替换和遗传性主动脉综合征患者。
- 对至少12个月随访的患者评估主要结局迁移和迁移距离,并与符合相同入选标准的ZDEG患者进行1:1倾向性评分匹配比较。
主要发现
- ZTEG组围术期无逆行性A型主动脉夹层(rTAAD)或壁内血肿发生。
- ZTEG组Ia型内漏和近端再干预率在20个月时均为6%(IQR 1-54.5)。
- ZTEG组1年和最大随访迁移率分别为2%和20%,中位迁移距离分别为2 mm(IQR 0-5)和5 mm(IQR 2-9)。
- 倾向性评分匹配比较显示,ZTEG组1年迁移率显著低于ZDEG组(4% vs 35%;p=0.04)。
- 最大随访时ZTEG组中位迁移距离显著短于ZDEG组[4 mm(IQR 0-9.5)vs 10 mm(IQR 6-15.5);p=0.016]。
临床怎么用
- 对于主动脉综合征患者,倒钩主动固定的ZTEG可能减少远端迁移,且不增加逆行性夹层风险。
- 现有关于主动固定导致不良事件的担忧在本研究未得到支持,但需结合患者个体情况选择移植物。
局限性
- 单中心回顾性设计,样本量有限,匹配比较仅纳入23例ZDEG患者。
- 迁移评估仅限65例随访至少12个月的患者,可能存在选择偏倚。
- 排除近端锚定区替换和遗传性主动脉综合征患者,结论外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Active fixation thoracic endografts have been presumed to cause adverse events in patients with aortic syndromes. This study evaluated the outcomes of a barb-fixated thoracic endograft and compared with a non-actively fixated endograft in patients managed for aortic syndromes. MATERIALS AND METHODS: A single center retrospective analysis was conducted using the STROBE guidelines. Patients treated for aortic syndromes with the barb-fixated Zenith TX2 TAA Endovascular Graft (ZTEG) between January 2011 and June 2024 were included. Patients with replaced proximal landing zones and genetic aortic syndromes were excluded. Primary outcomes were migration and migration distance (MD) in patients with at least 12 months of follow-up. A propensity-score matched comparison (1:1) to patients treated with the non-active fixation Zenith TX2 Dissection Endovascular Graft (ZDEG) was performed, after applying the same eligibility criteria. RESULTS: Ninety-six patients treated with ZTEG were included. No perioperative retrograde type A aortic dissection (rTAAD) or intramural hematoma occurred. Both endoleak Ia and proximal reintervention rates were 6%, each, at 20 months (IQR, 1-54.5). Endograft migration was assessed in 65 patients [median (IQR) follow-up: 33 months (IQR 20-71)], showing a 2 and 20% migration at 1 year and maximum follow-up, respectively, with a median MD of 2 mm (IQR 0-5) and 5 mm (IQR 2-9) at the same timepoints, respectively. The propensity score-matched comparison with 23 ZDEG patients revealed significantly lower 1-year migration (4% vs 35%; p=0.04) and shorter median MD [4 mm (IQR 0-9.5) vs 10 mm (IQR 6-15.5); p=0.016] at maximum follow-up for the ZTEG group. No difference was observed in endoleak Ia, proximal reintervention, or rTAAD rates at any point. CONCLUSION: The use of barb-mediated fixation ZTEG endograft in patients with aortic syndromes demonstrated reduced migration and MD compared with the non-actively fixated ZDEG, without differences in rTAAD, endoleak Ia, or proximal reintervention during follow-up.Clinical ImpactThoracic endovascular aortic repair with a barb-fixated endograft (Zenith TX2 TAA Endovascular Graft; ZTEG) in patients with aortic syndromes demonstrated migration rates of 2% at 1 year and 20% at maximum follow-up, with no retrograde dissection (rTAAD). In a propensity score-matched comparison with a non-active fixation endograft (Zenith TX2 Dissection Endovascular Graft; ZDEG), ZTEG showed significantly lower 1-year migration and shorter migration distance at maximum follow-up. No difference was observed in endoleak Ia, proximal reintervention, or rTAAD at any time point. These findings suggest that ZTEG may reduce distal migration without compromising safety regarding retrograde dissection, contrary to existing concerns.
引用
- Apostolidis G, Nana P, Panuccio G, et al. A Retrospective Analysis of Barb-mediated Active Fixation Impact on Thoracic Endovascular Aortic Repair Outcomes. J Endovasc Ther. 2026. PMID: 41857800. doi:10.1177/15266028261428265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。